tenofovir has been researched along with Encephalitis, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavegnano, C; Haile, WB; Jiang, Y; Schinazi, RF; Tao, S; Tyor, WR | 1 |
| Ciarlini, P; Folkerth, RD; Henrich, TJ; Johnson, JA; Klein, JP; Lyons, JL; Milner, DA; Phillips, RE; Schutten, M; Wood, BR | 1 |
1 review(s) available for tenofovir and Encephalitis, Viral
| Article | Year |
|---|---|
HIV-2 encephalitis: case report and literature review.
Topics: Adenine; Anti-HIV Agents; Brain; CD4 Lymphocyte Count; Deoxycytidine; Drug Combinations; Emtricitabine; Encephalitis, Viral; HIV-2; Humans; Lopinavir; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphonates; Ritonavir; RNA, Viral; Tenofovir; Viral Load | 2012 |
1 other study(ies) available for tenofovir and Encephalitis, Viral
| Article | Year |
|---|---|
The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model.
Topics: Animals; Antiviral Agents; Astrocytes; Blood-Brain Barrier; Disease Models, Animal; Encephalitis, Viral; Gliosis; HIV Infections; HIV-1; Humans; Janus Kinase Inhibitors; Macrophages; Male; Mice; Monocytes; Nitriles; Pyrazoles; Pyrimidines; Tenofovir; Virus Replication | 2016 |